Abstract
The potential of anticholinergics to provide bronchodilatory benefits over short-acting beta(2)-agonists (SABA) alone in patients with moderate-to-severe persistent asthma has not been well defined. An outpatient, randomized, double-blind, single-dose, crossover study in adult asthmatics with moderate-to-severe obstruction despite treatment with inhaled corticosteroids (ICS) was conducted comparing the fixed combination of ipratropium and albuterol (IB+ALB) to albuterol alone (ALB). Serial spirometry was performed over 6h. SABA were withheld for 8h, ICS and LABA for 24h. A total of 113 patients were randomized, 106 completed the study (males n=47; mean+/-SD age=51+/-13 years). Mean+/-SD baseline FEV(1)=1.4+/-0.5 L (49+/-12% predicted). IB+ALB resulted in significantly greater improvements over ALB in the average improvement over baseline in FEV(1) as approximated from the area under the curve from 0 to 6h after drug administration (72 ml, p<0.01) and mean peak FEV(1) response (55 ml, p<0.01) as well as higher FEV(1) responses at individual time points from 0.5 to 6h postdose (p<0.01 for all). Time to onset of response was similar between groups but time to peak and duration of response were longer with IB+ALB versus ALB (120 ve...Continue Reading
References
Dec 1, 1978·British Journal of Clinical Pharmacology·G E MarlinN Berend
Jan 1, 1988·Chest·J F MorrisD R Thomas
Jan 1, 1984·Annual Review of Medicine·J A Nadel, P J Barnes
Nov 22, 1984·The New England Journal of Medicine·M Kneussl, F Kummer
Nov 1, 1995·Chest·R BhagatD W Cockcroft
Sep 1, 1996·Chest·J P KarpelT J Witek
Feb 1, 1997·Chest·J M FitzGeraldK R Chapman
Aug 1, 1997·The Journal of Allergy and Clinical Immunology·J E GarrettA M Kelly
Sep 3, 1998·Chest·S F LanesJ P Karpel
May 6, 1999·American Journal of Respiratory and Critical Care Medicine·H S NelsonS W Yancey
Jun 26, 1999·Annals of Emergency Medicine·R G StoodleyR E Dales
Jun 14, 2000·American Journal of Respiratory and Critical Care Medicine·G J Rodrigo, C Rodrigo
Nov 9, 2000·American Journal of Respiratory and Critical Care Medicine·A F Gelb, N Zamel
Jun 19, 2001·The European Respiratory Journal·S L JonesD R Taylor
Mar 13, 2002·Chest·Arthur F GelbNoe Zamel
Jun 18, 2002·Chest·Gustavo J Rodrigo, Carlos Rodrigo
Feb 21, 2006·European Journal of Pharmacology·Nicholas J Gross
Nov 7, 2006·Clinical Reviews in Allergy & Immunology·Sarah Haney, Robert J Hancox
Citations
Oct 7, 2014·Current Allergy and Asthma Reports·Xavier Soler, Joe Ramsdell
Oct 22, 2011·World Journal of Pediatrics : WJP·Xiao-Fang Wang, Jian-Guo Hong
Jul 3, 2010·Journal of Pharmacological and Toxicological Methods·Alexander McNamaraWilliam J Martin
Jan 5, 2010·Journal of Pharmaceutical and Biomedical Analysis·Gajanan B Kasawar, Mazahar Farooqui
Nov 13, 2009·Medical Hypotheses·Nestor A Molfino
Mar 3, 2011·Allergology International : Official Journal of the Japanese Society of Allergology·Hirofumi KiyokawaMichiaki Mishima
Nov 2, 2013·Clinical Reviews in Allergy & Immunology·T E AlbertsonS Louie
May 1, 2016·BMC Pulmonary Medicine·James F DonohueEugene R Bleecker
Sep 8, 2010·The New England Journal of Medicine·Stephen C Lazarus
May 18, 2012·The Cochrane Database of Systematic Reviews·Bhupendrasinh F Chauhan, Francine M Ducharme
Nov 22, 2014·Current Opinion in Pulmonary Medicine·Linda Rogers, Nicola A Hanania
Jul 14, 2012·Expert Review of Respiratory Medicine·Federica NovelliPierluigi Paggiaro
Mar 31, 2020·The American Journal of Emergency Medicine·Brit LongMichael Gottlieb